| Literature DB >> 31961471 |
Hesam Arabnejad1, Elvira Bombino1, Dana I Colpa1, Peter A Jekel1, Milos Trajkovic1, Hein J Wijma1, Dick B Janssen1.
Abstract
The use of enzymes in preparative biocatalysis often requires tailoring enzyme selectivity by protein engineering. Herein we explore the use of computational library design and molecular dynamics simulations to create variants of limonene epoxide hydrolase that produce enantiomeric diols from meso-epoxides. Three substrates of different sizes were targeted: cis-2,3-butene oxide, cyclopentene oxide, and cis-stilbene oxide. Most of the 28 designs tested were active and showed the predicted enantioselectivity. Excellent enantioselectivities were obtained for the bulky substrate cis-stilbene oxide, and enantiocomplementary mutants produced (S,S)- and (R,R)-stilbene diol with >97 % enantiomeric excess. An (R,R)-selective mutant was used to prepare (R,R)-stilbene diol with high enantiopurity (98 % conversion into diol, >99 % ee). Some variants displayed higher catalytic rates (kcat ) than the original enzyme, but in most cases KM values increased as well. The results demonstrate the feasibility of computational design and screening to engineer enantioselective epoxide hydrolase variants with very limited laboratory screening.Entities:
Keywords: computational design; enantioselectivity; epoxide hydrolase; molecular dynamics; stilbene oxide
Mesh:
Substances:
Year: 2020 PMID: 31961471 PMCID: PMC7383614 DOI: 10.1002/cbic.201900726
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164
Scheme 1Conversion of epoxides by limonene epoxide hydrolase. A) regioselective hydrolysis of meso‐epoxides examined in this study. B) Catalytic mechanism of LEH, illustrated with proRR hydrolysis of cyclopentene oxide.
Figure 1Design of limonene epoxide hydrolases for asymmetric conversion of meso‐epoxides. A) NAC criteria used to predict the enantioselectivity of diol formation from 2,3‐butene oxide by MD simulations. The same criteria were used for all three epoxides. Angles and distances are defined as followed: for the nucleophilic attack angle θ1A=128–163°, θ1B=128–163° and d 1=0–3.22 Å. For the H‐bonds θ2‐6=120–180° and d 2‐6=0–3.50 Å. B) selection of target positions (cyan) in PDB structure PDB 4R9K. Catalytic residues are shown in yellow, and the substrate in magenta. The targeted amino acid positions are either located in the peripheral structural elements H1 (M32, L35), H3 (L74), and β3 (M78, I80, V83) which border the proRR side of the substrate binding pocket; or in the central region, which forms the proSS side of the binding pocket and consists of H4 (F139), β4 (L103), β5 (L114, I116) and β6 (F134). The secondary structure elements are defined as follows: N‐loop (residues 1 to 23), H1 (24 to 35), H2 (40 to 46), H3 (64 to 75), H4 (135 to 143), β1 (52 to 56), β2 (60 to 62), β3 (79 to 91), β4 (94 to 105), β5 (111 to 123) and β6 (126 to 133).
Molecular dynamics screening of designed enzyme variants.
|
CASCO step |
Criteria |
No. of designs remaining for substrate | ||
|---|---|---|---|---|
|
|
|
| ||
|
Total Rosetta designs |
28 795 |
33 252 |
20 714 | |
|
Rosetta designs with a unique sequence |
4125 |
4732 |
6232 | |
|
Designs remaining after MD screening | ||||
|
5×10 ps |
|
711 |
990 |
2504 |
|
10×10 ps |
|
524 |
723 |
2205 |
|
20×10 ps |
|
378 |
587 |
1631 |
|
40×10 ps |
|
170 |
314 |
1284 |
|
80×10 ps |
|
142 |
283 |
978[a] |
|
5×100 ps |
|
63 |
181 |
442[b] |
|
Rosetta designs passing all criteria |
1.5 % |
3.8 % |
7.1 % | |
[a] [NAC]pref indicates the NAC frequency for the preferred product enantiomer. Additional criterion [NAC]pref >10 %. [b] Additional criterion [NAC]pref >5 %.
Predicted and observed activities of computationally redesigned limonene epoxide hydrolase variants.
|
Enzyme |
|
Mutations[a] |
Computational |
Experimental |
| |||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
NAC % |
NAC % |
|
|
Act. |
|
|
|
|
|
proRR |
proSS |
[%] |
[%][b] |
[%][c] |
[°C] |
|
|
|
cyclopentene oxide ( |
|
|
|
|
|
|
|
LEH‐P |
|
|
|
|
|
14 |
0.12 U mg−1 |
70 |
|
Designs for ( |
1A |
|
5.63 |
0.000 |
100 |
32 |
2 |
63.5 |
|
43A |
|
3.86 |
0.040 |
98 |
9 |
29 |
67.0 | |
|
59A |
|
2.59 |
0.008 |
99 |
6 |
1 |
67.0 | |
|
45A |
|
2.44 |
0.000 |
100 |
–[d] |
<1 |
– | |
|
46C |
|
2.08 |
0.000 |
100 |
46 |
24 |
57.0 | |
|
Designs for ( |
3A |
|
0.280 |
36.5 |
−98 |
−74 |
41 |
– |
|
4C |
|
0.208 |
24.1 |
−98 |
−80 |
55 |
48.5 | |
|
24A |
|
0.248 |
23.6 |
−98 |
−85 |
15 |
68.5 | |
|
25A |
|
0.080 |
19.4 |
−99 |
−84 |
16 |
73.5 | |
|
26A |
|
0.240 |
19.3 |
−98 |
−60 |
164 |
45.5 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LEH‐P |
|
|
|
|
|
−2 |
0.23 U mg−1 |
|
|
Designs for ( |
47B |
|
24.1 |
0.176 |
99 |
57 |
3 |
56.5 |
|
48Ae |
|
9.00 |
0.152 |
97 |
24 |
60 |
56.0 | |
|
45A |
|
5.72 |
0.112 |
96 |
18 |
1 |
– | |
|
49A |
L103V_L114W_I116L_F134G_F139W |
4.14 |
0.048 |
98 |
31 |
6 |
59.0 | |
|
50A |
|
2.90 |
0.040 |
97 |
−3 |
15 |
73.0 | |
|
Designs for ( |
30A |
|
0.496 |
25.2 |
−96 |
−73 |
11 |
70.5 |
|
31A |
|
0.320 |
23.7 |
−97 |
−41 |
100 |
56.0 | |
|
32A |
|
0.080 |
21.8 |
−99 |
−82 |
15 |
57.5 | |
|
33B |
|
0.168 |
21.0 |
−98 |
6 |
1 |
78.0 | |
|
26A |
|
0.080 |
20.4 |
−99 |
−60 |
87 |
45.5 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LEH‐P |
|
|
|
|
|
92 |
0.35 U mg−1 |
|
|
Designs for ( |
51Ae |
|
28.2 |
0.104 |
99 |
91 |
51 |
59.5 |
|
52A |
|
24.9 |
0.144 |
99 |
−97 |
22 |
61.0 | |
|
60Ae |
|
22.7 |
0.048 |
100 |
>99 |
52 |
65.0 | |
|
61B |
|
22.1 |
0.136 |
99 |
92 |
3 |
66.5 | |
|
38A |
|
22.0 |
0.352 |
97 |
>99 |
11 |
75.5 | |
|
Designs for ( |
62A |
|
0.016 |
15.5 |
−100 |
– |
<1 |
71.0 |
|
63B |
|
0.240 |
15.4 |
−97 |
40 |
7 |
67.0 | |
|
64C |
|
0.152 |
15.3 |
−98 |
– |
<1 |
57.5 | |
|
41B |
|
0.072 |
15.0 |
−99 |
−95 |
21 |
62.0 | |
|
65B |
|
0.008 |
14.7 |
−100 |
−28 |
2 |
66.0 | |
[a] Mutations at the peripheral (proRR side) of the substrate binding pocket are underlined. Other mutations line the center (proSS side) of the substrate binding pocket. [b] Positive numbers: (R,R)‐diol preference; negative numbers: (S,S)‐diol preference. [c] Relative activities expressed in percentage of the activity with the template enzyme (indicated). Data from duplicate measurements with the same enzyme batch. [d] –, no activity. [e] Variants designed by Rosetta to exhibit (S,S)‐product selectivity but predicted by HTMI‐MD and found experimentally to produce (R,R)‐diol 3 b.
Kinetic properties of computationally redesigned epoxide hydrolases.
|
Variant |
Designed to produce |
Assay substrate |
|
Preference |
|
|
|
|---|---|---|---|---|---|---|---|
|
LEH‐P |
– |
|
13 |
( |
0.035±0.004 |
4.2±0.2 |
7.9 |
|
RR8 |
( |
|
85 |
( |
0.039±0.009 |
189±20 |
0.20 |
|
46C |
( |
|
34 |
( |
0.022±0.002 |
344±17 |
0.06 |
|
43A |
( |
|
8 |
( |
0.017±0.005[c] |
35±4[c] |
0.48 |
|
SS16 |
( |
|
−90 |
( |
0.062±0.001 |
54±4 |
1.14 |
|
24A |
( |
|
−85 |
( |
0.005±0.001 |
3±0.2 |
1.9 |
|
LEH‐P |
– |
|
24 |
( |
0.056±0.010 |
18±1 |
3.1 |
|
32A |
( |
|
−82 |
( |
0.063±0.002 |
225±9 |
0.28 |
|
LEH‐P |
– |
|
92 |
( |
0.147±0.012 |
0.37±0.02 |
406 |
|
60A |
( |
|
>99 |
( |
0.052±0.006 |
0.06±0.01 |
890 |
|
52A |
( |
|
−89 |
( |
0.003±0.001 |
0.16±0.03 |
19 |
|
41B |
( |
|
−94 |
( |
0.002±0.001 |
0.19±0.02 |
10.5 |
[a] Calculated from multiple data points that is, product enantiomers in different reactions. [b] Averages of duplicate measurements with standard deviation. [c] Single measurement; margins from average coefficient of variation for 1 a data.
Asymmetric synthesis of stilbene diols by computationally engineered enantiocomplementary epoxide hydrolases.[a]
|
|
Temp [°C] |
Time [h] |
Conversion [%] |
|
|---|---|---|---|---|
|
Production of ( | ||||
|
HEPES 50 m |
30 |
44 |
63 |
–[b] |
|
10 % 1,4‐dioxane |
30 |
44 |
78 |
– |
|
10 % THF |
30 |
44 |
52 |
– |
|
At 40 °C |
40 |
44 |
80 |
– |
|
10 % 1,4‐dioxane |
40 |
24 |
76 |
– |
|
10 % 1,4‐dioxane |
40 |
48 |
86 |
– |
|
15 % 1,4‐dioxane |
40 |
48 |
98 |
>99 % ( |
|
Production of ( | ||||
|
HEPES 50 m |
30 |
44 |
38 |
– |
|
10 % 1,4‐dioxane |
40 |
24 |
50 |
– |
|
10 % 1,4‐dioxane |
40 |
48 |
63 |
88 % ( |
|
15 % 1,4‐dioxane |
40 |
48 |
18 |
– |
[a] Reaction mixtures (total volume 1 mL) contained 10 mg cis‐stilbene oxide (final concentration 50 mm, suspension) and 6.37 mg enzyme (final concentration 320 μm) in 50 mm HEPES, pH 8.0. [b] –, not determined.
Figure 2Structural basis of redesigned enantioselectivity. Shown are the active‐site cavities of three proSS‐ variants (blue shades, names indicated) and three proRR variants (yellow‐orange shades). The variants were designed for the substrates indicated at the left of each pair of panels. The reacting water molecules are shown. Hydrogen atoms of substrates are hidden for clarity. In each panel, both the designed enzyme with its substrate is shown, as well the position of the same substrate in the opposite design (substrates in proSS designs in cyan, substrates in proRR designs in yellow). This shows pronounced differences in substrate positioning and how steric hindrance steers product enantioselectivity.